Cutrer FM - Search Results

1

The use of multiattribute decision models in evaluating triptan treatment options in migraine.

Ferrari MD, Goadsby PJ, Lipton RB, Dodick DW, Cutrer FM, McCrory D, Williams P. Ferrari MD, et al. Among authors: cutrer fm. J Neurol. 2005 Sep;252(9):1026-32. doi: 10.1007/s00415-005-0769-0. Epub 2005 Mar 11. J Neurol. 2005. PMID: 15761676

2

Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project.

Dodick DW, Lipton RB, Ferrari MD, Goadsby PJ, McCrory D, Cutrer FM, Williams P. Dodick DW, et al. Among authors: cutrer fm. Curr Pain Headache Rep. 2004 Dec;8(6):435-42. doi: 10.1007/s11916-004-0064-2. Curr Pain Headache Rep. 2004. PMID: 15509456 Review.

3

Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project).

Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P. Cutrer FM, et al. Clin Ther. 2004 Sep;26(9):1533-45. doi: 10.1016/j.clinthera.2004.09.011. Clin Ther. 2004. PMID: 15531016

4

How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians.

Lipton RB, Cutrer FM, Goadsby PJ, Ferrari MD, Dodick DW, McCrory D, Liberman JN, Williams P. Lipton RB, et al. Among authors: cutrer fm. Curr Med Res Opin. 2005 Mar;21(3):413-24. doi: 10.1185/030079905X36387. Curr Med Res Opin. 2005. PMID: 15811210

5

Pathophysiology of migraine.

Cutrer FM. Cutrer FM. Semin Neurol. 2006 Apr;26(2):171-80. doi: 10.1055/s-2006-939917. Semin Neurol. 2006. PMID: 16628527 Review.

6

Pathophysiology of migraine.

Cutrer FM. Cutrer FM. Semin Neurol. 2010 Apr;30(2):120-30. doi: 10.1055/s-0030-1249222. Epub 2010 Mar 29. Semin Neurol. 2010. PMID: 20352582 Review.

7

Migraine clinical diagnostic criteria.

Cutrer FM, Martin VT. Cutrer FM, et al. Handb Clin Neurol. 2010;97:295-302. doi: 10.1016/S0072-9752(10)97024-3. Handb Clin Neurol. 2010. PMID: 20816430 No abstract available.

8

MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments.

Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD, Cutrer FM. Tepper SJ, et al. Among authors: cutrer fm. Mayo Clin Proc. 2011 Oct;86(10):948-55. doi: 10.4065/mcp.2011.0093. Mayo Clin Proc. 2011. PMID: 21964172 Free PMC article. Clinical Trial.

9

Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.

Schwedt TJ, Sahai-Srivastava S, Murinova N, Birlea M, Ahmed Z, Digre K, Lopez K, Mullally W, Blaya MT, Pippitt K, Cutrer FM, DeLange J, Schecht H, Rizzoli P, Lane J, Wald J, Cortez MM, Martin VT, Spare NM, Hentz JG, Robert T, Dodick DW; MOTS Investigators. Schwedt TJ, et al. Among authors: cutrer fm. Cephalalgia. 2021 Sep;41(10):1053-1064. doi: 10.1177/03331024211006903. Epub 2021 May 2. Cephalalgia. 2021. PMID: 33938249

10

Migraine with aura associates with a higher artificial intelligence: ECG atrial fibrillation prediction model output compared to migraine without aura in both women and men.

Chiang CC, Chhabra N, Chao CJ, Wang H, Zhang N, Lim E, Baez-Suarez A, Attia ZI, Schwedt TJ, Dodick DW, Cutrer FM, Friedman PA, Noseworthy PA. Chiang CC, et al. Among authors: cutrer fm. Headache. 2022 Sep;62(8):939-951. doi: 10.1111/head.14339. Epub 2022 Jun 8. Headache. 2022. PMID: 35676887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters